Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
06/2003
06/11/2003CN1423645A 维他命d类似物 Vitamin d analogues
06/11/2003CN1423638A Ox (adi) azolyl-hydroxamic acids useful as procollagen C-proteinase inhibitors
06/11/2003CN1423633A Azetidine derivatives, preparation thereof and pharmaceutical compositions
06/11/2003CN1423557A Intracorporeal medicaments for photodynamic treatment of disease
06/11/2003CN1423528A Nutritional modules
06/11/2003CN1422663A Chinese medicine preparation for preventing and treating throat and oral cavity diseases and preparation method
06/11/2003CN1422656A Chinese medicinal preparation for treating liver disease
06/11/2003CN1422626A Pseudo-ginseng instant powder and its preparation method
06/11/2003CN1422613A Liver-tonifying medicine slow-release plaster
06/11/2003CN1111064C Hepatitis treating medicine and its production process
06/11/2003CN1111062C Chinese medicine for treating habitual constipation
06/11/2003CN1111060C Medicine for treating viral hepatitis
06/11/2003CN1111052C ÔÇÿTongrundanÔÇÖ pill
06/11/2003CN1111040C Hepatitis treating medicine
06/11/2003CN1111035C Chinese medicine for curing gastroenteritic diseases
06/11/2003CN1111034C Gel for treating tooth anaphylactia
06/11/2003CA2513347A1 The effect of a buffering agent on acidogenesis of plaque
06/10/2003US6576793 β2-adrenergic receptor agonists
06/10/2003US6576762 Heteroaromatic substituted amides with antagonistic activity to neurokinin 1 receptors
06/10/2003US6576759 Antiproliferative agents; anticancer agents; rheumatic disorders; administering nucleotide
06/10/2003US6576669 Use of an LTB4 antagonist for the treatment or prevention of diseases caused by increased expression of mucin genes
06/10/2003US6576650 No central nervous system side effects
06/10/2003US6576648 Compound with growth hormone releasing properties
06/10/2003US6576644 Treating sexual dysfunction including erectile dysfunction, diabetes melitus, gastrointestinal disorders, including gastric paresis and cardiovascular disorders; cyclic guanosine 3',5'-monophosphate (cGMP)
06/10/2003US6576640 Rapidly penetration into central nervous system; treating noradrenaline deficiency; depression, Parkinson's disease
06/10/2003US6576626 Treating gastro-oesophageal reflux disease
06/10/2003US6576434 Transport protein of given amino acid sequence; exposing cells that express the protein to compound; measuring ion transport; use in treatment of interleukin mediated atopic allergy, asthma and cystic fibrosis
06/10/2003US6576260 Sustained-release form of administration containing tramadol saccharinate
06/10/2003CA2350195C Rapid onset formulation of pyridoxine hydrochloride and doxylamine succinate
06/10/2003CA2192354C Corticotropin releasing factor against antagonist
06/10/2003CA2072047C Pharmaceutical compositions
06/06/2003CA2436943A1 Hydantoin compounds useful as anti-inflammatory agents
06/05/2003WO2003046580A1 Assay for screening candidate drugs for the treatment of inflammatory diseases
06/05/2003WO2003046135A2 Osteopontin-related compositions and methods
06/05/2003WO2003046008A1 Therapeutic use of antibodies and fragments thereof binding primate ifn-gamma
06/05/2003WO2003045999A2 Human vanilloid receptor protein and polynucleotide sequence encoding same
06/05/2003WO2003045978A2 Antagonist anti-cd40 monoclonal antibody therapy for multiple sclerosis treatment
06/05/2003WO2003045974A2 Methods and compositions for derepression of iap-inhibited caspase
06/05/2003WO2003045967A1 Aryl fused azapolycyclic compounds
06/05/2003WO2003045951A1 Triazolo[4,3-a]pyrido[2,3-d]pyrimidin-5-one derivatives, compositions containing same, preparation method and use thereof
06/05/2003WO2003045944A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors
06/05/2003WO2003045942A2 Chemokine receptor antagonists and methods of use thereof
06/05/2003WO2003045926A1 5-sulphanyl-4h-1,2,4-triazole derivatives and their use as medicine
06/05/2003WO2003045921A1 Heterocyclic amide compounds as apolipoprotein b inhibitors
06/05/2003WO2003045920A1 4-aminoquinoline compounds
06/05/2003WO2003045918A1 Piperidine-based mch antagonists for treatment of obesity and cns disorders
06/05/2003WO2003045917A2 Ccr-3 receptor antagonists vii
06/05/2003WO2003045437A1 Pharmaceutical compositions of 5,7,14-triazatetracyclo[10.3.1.0(2,11).0(4,9)]-hexadeca-2(11)3,5,7,9-pentaene
06/05/2003WO2003045430A1 Tnf-alpha inhibitors for the treatment of hepatic diseases
06/05/2003WO2003045412A1 Mint extract and related pharmaceutical compositions
06/05/2003WO2003045411A2 Ginger extract preparation
06/05/2003WO2003045409A1 A pharmaceutical composition made from chinese traditional medecine and method of producing thereof
06/05/2003WO2003045403A1 Method of treating halitosis
06/05/2003WO2003045401A1 Compositions and methods for animal treatment
06/05/2003WO2003045394A1 Succinic acid salts of 5,8,14-triazatetracyclo'10.3.1.0<2,11>.0<4,9>-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof
06/05/2003WO2003045393A1 Piperazine derivatives for use as ccr-3 receptor antagonists in the treatment of asthma
06/05/2003WO2003045360A2 Use of gaba for the treatment of intestinal inflammations
06/05/2003WO2003045356A1 Pharmaceutical dosage form with multiple coatings
06/05/2003WO2003045333A2 Treatment of hyperproliferative diseases using active vitamin d analogues
06/05/2003WO2003045318A2 Manipulation of cytokine levels using cd83 gene products
06/05/2003WO2003045317A2 Therapeutic protein and treatments
06/05/2003WO2003045316A2 Polynucleotide therapy
06/05/2003WO2003045313A2 2-aminoquinoline compounds
06/05/2003WO2003045229A2 Methods and compositions for treating cancer
06/05/2003WO2003045228A2 Methods for treating autoimmune disorders, and reagents related thereto
06/05/2003WO2002085843A3 Process for the preparation of 1,3-substituted indenes and aryl-fused azapolycyclic compounds
06/05/2003WO2002074924A3 Method for measuring serine palmitoyltransferase in mammalian tissue and use thereof
06/05/2003WO2002074275A3 Systems for delivering a cosmetic and/or therapeutic active to oral surfaces
06/05/2003WO2002074099A3 Polybutene containing chewing gum and confection
06/05/2003WO2002060932A3 A serpin in bifidobacteria
06/05/2003WO2002058712A3 Probiotic compounds derived from lactobacillus casei strain ke01
06/05/2003WO2002048124A3 Piperazine derivatives
06/05/2003WO2002046230A3 G-protein coupled receptors
06/05/2003US20030105336 Pyrazole derivatives, their preparation and their use in pharmaceuticals
06/05/2003US20030105333 RXR activating molecules
06/05/2003US20030105318 G-protein transmembrane domain; protein synthesis inhibitor; neurotransmitter
06/05/2003US20030105168 Composition comprising ubiquinone
06/05/2003US20030105165 Gap junctions and EDHF
06/05/2003US20030105148 Selective estrogen receptor modulators
06/05/2003US20030105147 Analgesics, sedatives, anesthetics
06/05/2003US20030105142 Amide derivatives useful as inhibitors of the production of cytokines
06/05/2003US20030105135 Adrenergic receptors; gastrointestinal disorders, dietetics, urogenital disorders, antidiabetic agents
06/05/2003US20030105123 For therapy of respiratory system disorders
06/05/2003US20030105118 Tricyclic quinazolinediones
06/05/2003US20030105114 Methods of treatment and kits comprising a growth hormone secretagogue
06/05/2003US20030105110 Novel compounds
06/05/2003US20030105107 Novel lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines
06/05/2003US20030105106 5-HT receptor ligands and uses thereof
06/05/2003US20030105092 Prevention of loss and restoration of bone mass by certain prostaglandin agonists
06/05/2003US20030105090 For therapy of cancer, diabetes
06/05/2003US20030105087 New polycyclic azaindole compounds
06/05/2003US20030105085 Antagonists of MCP-1 function and methods of use thereof
06/05/2003US20030105084 Compound which inhibit the release of inflammatory cytokines
06/05/2003US20030105050 Disorders caused by overproduction of collagen fibres, for example, liver cirrhosis, kidney, liver and heart fibrosis, scleroderma, hypertrophic scars and keloids
06/05/2003US20030105031 Administering therapeutically effective amount of one or more flavonoids and carrier for therapy of reactive and inflammatory dermatoses
06/05/2003US20030105027 Nutritional supplements and methods for prevention, reduction and treatment of radiation injury
06/05/2003US20030104992 A cyclic polypeptides; immunosuppressive anti-inflammatory activity, inhibiting antigen-induced inflammatory cell infiltration
06/05/2003US20030104975 Useful for identification of compounds that induce or inhibit the recruitment of the p160 family cofactors, especially TIF-2 and/ or SRCs cofactors (Translation initiation factor-2 and steroid receptor cofactors)
06/05/2003US20030104974 Dual inhibitorsof PDE 7 and PDE 4
06/05/2003US20030104579 Pluripotent stem cells; antitumor agents; antiproliferative agents; antiinflammatory agents; veterinary medicine; tissue engineering
1 ... 875 876 877 878 879 880 881 882 883 884 885 886 887 888 889 890 891 892 893 894 895 ... 1258